Literature DB >> 11082115

Effects of inhibition of calcium and potassium currents in guinea-pig cardiac contraction: comparison of beta-caryophyllene oxide, eugenol, and nifedipine.

O Sensch1, W Vierling, W Brandt, M Reiter.   

Abstract

1. To investigate the effects of the clove oil constituents beta-caryophyllene oxide and eugenol on the heart muscle, experiments were performed on isolated papillary muscles and on ventricular myocytes of the guinea-pig. The results were compared with those obtained with the dihydropyridine, nifedipine. 2. All three substances exerted negative inotropic effects in heart muscle although with different potencies and different influences on the time course of the contraction curve. 3. They all reduced rested-state contractions (RSCs) in the presence of isoprenaline which are thought to be due to the Ca(2+) current (I(Ca)). 4. beta-Caryophyllene oxide, eugenol and nifedipine inhibited the I(Ca) in single cells from the guinea-pig ventricle in a concentration-dependent, reversible way, but with different potencies. 5. In addition to the I(Ca)-inhibiting effect, beta-caryophyllene oxide strongly inhibited and eugenol slightly inhibited the potassium current. 6. The action potential of papillary muscles at a 1 Hz contraction frequency was greatly shortened by nifedipine, slightly shortened by eugenol, but not changed by beta-caryophyllene oxide. 7. The inhibition of the potassium current by beta-caryophyllene oxide obviously prevents a shortening of the action potential due to the diminution of the I(Ca). Accordingly, the negative inotropic effect of beta-caryophyllene oxide is closely related to the inhibition of I(Ca). In contrast, eugenol and nifedipine, which shorten the action potential, exert stronger negative inotropic effects than expected from their influence on I(Ca). 8. The results show that the negative inotropic effect of a calcium channel blocker can be attenuated by an additional inhibition of potassium channels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082115      PMCID: PMC1572431          DOI: 10.1038/sj.bjp.0703673

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Analysis of the effects of changes in rate and rhythm upon myocardial contractility.

Authors:  J R BLINKS; J KOCH-WESER
Journal:  J Pharmacol Exp Ther       Date:  1961-12       Impact factor: 4.030

2.  Automatic log P estimation based on combined additive modeling methods.

Authors:  T Suzuki; Y Kudo
Journal:  J Comput Aided Mol Des       Date:  1990-06       Impact factor: 3.686

3.  Pharmacological evidence for two types of myocardial sarcoplasmic reticulum Ca2+ release.

Authors:  C Lynch
Journal:  Am J Physiol       Date:  1991-03

4.  Electrophysiological effects of CD-349, a dihydropyridine-type calcium antagonist, on goat cardiac Purkinje fibers.

Authors:  K Tsuchida; K Kaneko; H Aihara
Journal:  J Cardiovasc Pharmacol       Date:  1991-11       Impact factor: 3.105

5.  Electrophysiological analysis of the action of nifedipine and nicardipine on myocardial fibers.

Authors:  P Charnet; H Ouadid; S Richard; J Nargeot
Journal:  Fundam Clin Pharmacol       Date:  1987       Impact factor: 2.748

Review 6.  Calcium mobilization and cardiac inotropic mechanisms.

Authors:  M Reiter
Journal:  Pharmacol Rev       Date:  1988-09       Impact factor: 25.468

7.  Differential potentiation by depolarization of the effects of calcium antagonists on contraction and Ca2+ current in guinea-pig heart.

Authors:  R Okuyama; S Adachi-Akahane; T Nagao
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

8.  Characteristics of L-type calcium channel blockade by lacidipine in guinea-pig ventricular myocytes.

Authors:  E Cerbai; A Giotti; A Mugelli
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

9.  The antifungal antibiotic clotrimazole potently inhibits L-type calcium current in guinea-pig ventricular myocytes.

Authors:  G P Thomas; M Karmazyn; A C Zygmunt; C Antzelevitch; N Narayanan
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

10.  Cardiovascular effects of the new dihydropyridine derivative elgodipine.

Authors:  J Tamargo; J López-Sendón; E Delpón; M González-Morales; E de Miguel
Journal:  Arzneimittelforschung       Date:  1991-09
View more
  8 in total

1.  Characterizing the effects of Eugenol on neuronal ionic currents and hyperexcitability.

Authors:  Chin-Wei Huang; Julie Chi Chow; Jing-Jane Tsai; Sheng-Nan Wu
Journal:  Psychopharmacology (Berl)       Date:  2011-12-13       Impact factor: 4.530

2.  Acute effect of essential oil of Eugenia caryophyllata on cognition and pain in mice.

Authors:  Sumita Halder; Ashish K Mehta; Pramod K Mediratta; Krishna K Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-03-28       Impact factor: 3.000

3.  Inhibition of Nav1.7 channels by methyl eugenol as a mechanism underlying its antinociceptive and anesthetic actions.

Authors:  Ze-Jun Wang; Boris Tabakoff; Simon R Levinson; Thomas Heinbockel
Journal:  Acta Pharmacol Sin       Date:  2015-06-08       Impact factor: 6.150

4.  Effects of eugenol on resting tension of rat atria.

Authors:  R R Olivoto; C E N Damiani; I Kassouf Silva; M S Lofrano-Alves; M A Oliveira; R T H Fogaça
Journal:  Braz J Med Biol Res       Date:  2014-03-21       Impact factor: 2.590

Review 5.  Pharmacological Properties and Health Benefits of Eugenol: A Comprehensive Review.

Authors:  Muhammad Farrukh Nisar; Mahnoor Khadim; Muhammad Rafiq; Jinyin Chen; Yali Yang; Chunpeng Craig Wan
Journal:  Oxid Med Cell Longev       Date:  2021-08-03       Impact factor: 6.543

6.  Downregulation of CYP17A1 by 20-hydroxyecdysone: plasma progesterone and its vasodilatory properties.

Authors:  Maneera Y Aljaber; Nelson N Orie; Asmaa Raees; Suhail Kraiem; Mashael Al-Jaber; Waseem Samsam; Mostafa M Hamza; David Abraham; Norman M Kneteman; Alka Beotra; Vidya Mohamed-Ali; Mohammed Almaadheed
Journal:  Future Sci OA       Date:  2022-07-07

7.  Association of rat thoracic aorta dilatation by astragaloside IV with the generation of endothelium-derived hyperpolarizing factors and nitric oxide, and the blockade of Ca2+ channels.

Authors:  Guanying Hu; Xixiong Li; Sanyin Zhang; Xin Wang
Journal:  Biomed Rep       Date:  2016-05-18

8.  The Role of Eugenol in the Prevention of Acute Pancreatitis-Induced Acute Kidney Injury: Experimental Study.

Authors:  Charalampos Markakis; Alexandra Tsaroucha; Apostolos E Papalois; Maria Lambropoulou; Eleftherios Spartalis; Christina Tsigalou; Konstantinos Romanidis; Constantinos Simopoulos
Journal:  HPB Surg       Date:  2016-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.